These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32171573)
21. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. Blank PR; Schwenkglenks M; Szucs TD J Infect; 2009 Jun; 58(6):446-58. PubMed ID: 19446340 [TBL] [Abstract][Full Text] [Related]
22. A Profile of Influenza Vaccine Coverage for 2019-2020: Database Study of the English Primary Care Sentinel Cohort. Hoang U; Delanerolle G; Fan X; Aspden C; Byford R; Ashraf M; Haag M; Elson W; Leston M; Anand S; Ferreira F; Joy M; Hobbs R; de Lusignan S JMIR Public Health Surveill; 2024 May; 10():e39297. PubMed ID: 38787605 [TBL] [Abstract][Full Text] [Related]
23. The contagious nature of a vaccine scare: How the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark. Gørtz M; Brewer NT; Hansen PR; Ejrnæs M Vaccine; 2020 Jun; 38(28):4432-4439. PubMed ID: 32418796 [TBL] [Abstract][Full Text] [Related]
24. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons. Blank PR; Schwenkglenks M; Szucs TD Infection; 2009 Oct; 37(5):390-400. PubMed ID: 19768382 [TBL] [Abstract][Full Text] [Related]
25. Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark. Amdisen L; Kristensen ML; Rytter D; Mølbak K; Valentiner-Branth P Vaccine; 2018 Sep; 36(38):5747-5753. PubMed ID: 30111513 [TBL] [Abstract][Full Text] [Related]
26. Childhood vaccination coverage in Italy: results of a seven-region survey. The Italian Vaccine Coverage Survey Working Group. Bull World Health Organ; 1994; 72(6):885-95. PubMed ID: 7867134 [TBL] [Abstract][Full Text] [Related]
28. Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK. Stuurman AL; Ciampini S; Vannacci A; Bella A; Rizzo C; Muñoz-Quiles C; Pandolfi E; Liyanage H; Haag M; Redlberger-Fritz M; Bonaiuti R; Beutels P PLoS One; 2021; 16(6):e0252836. PubMed ID: 34129638 [TBL] [Abstract][Full Text] [Related]
29. Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System. Irving SA; Groom HC; Stokley S; McNeil MM; Gee J; Smith N; Naleway AL Acad Pediatr; 2018 Mar; 18(2S):S85-S92. PubMed ID: 29502643 [TBL] [Abstract][Full Text] [Related]
31. Vaccination against influenza, measles, pertussis and varicella in workers in healthcare facilities in France: A national cross-sectional study in 2019. Vaux S; Fonteneau L; Péfau M; Venier AG; Gautier A; Altrach SS; Parneix P; Levy-Bruhl D Vaccine; 2023 Jan; 41(3):812-820. PubMed ID: 36528442 [TBL] [Abstract][Full Text] [Related]
32. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe. Uhart M; Bricout H; Clay E; Largeron N Hum Vaccin Immunother; 2016 Sep; 12(9):2259-68. PubMed ID: 27166916 [TBL] [Abstract][Full Text] [Related]
33. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019. Elam-Evans LD; Yankey D; Singleton JA; Sterrett N; Markowitz LE; Williams CL; Fredua B; McNamara L; Stokley S MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1109-1116. PubMed ID: 32817598 [TBL] [Abstract][Full Text] [Related]
34. Potential use of Western Australia’s mandatory Midwives Notification System for routinely monitoring antenatal vaccine coverage. Regan AK; Effler PV; Thomson C; Mak DB Commun Dis Intell (2018); 2019 Jun; 43():. PubMed ID: 31203587 [TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016. Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873 [TBL] [Abstract][Full Text] [Related]
36. Influenza vaccination coverage rates in the UK: a comparison of two monitoring methods during the 2002-2003 and 2003-2004 seasons. Müller D; Nguyen-Van-Tam JS; Szucs TD Public Health; 2006 Nov; 120(11):1074-80. PubMed ID: 17027881 [TBL] [Abstract][Full Text] [Related]
37. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination. Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346 [TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groups. Latsuzbaia A; Arbyn M; Weyers S; Mossong J Vaccine; 2018 Apr; 36(18):2411-2416. PubMed ID: 29602702 [TBL] [Abstract][Full Text] [Related]
39. Antenatal influenza and pertussis vaccination in Western Australia: a cross-sectional survey of vaccine uptake and influencing factors. Mak DB; Regan AK; Vo DT; Effler PV BMC Pregnancy Childbirth; 2018 Oct; 18(1):416. PubMed ID: 30355329 [TBL] [Abstract][Full Text] [Related]
40. Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy. Giaquinto C; Gabutti G; Baldo V; Villa M; Tramontan L; Raccanello N; Russo F; Poma C; Scamarcia A; Cantarutti L; Lundin R; Perinetti E; Cornen X; Thomas S; Ballandras C; Souverain A; Hartwig S BMC Infect Dis; 2018 Mar; 18(1):103. PubMed ID: 29506477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]